Abstract
Stroke is one of the leading causes of mortality, and several risk factors have been identified that may be modified to ameliorate this risk. Recently, obstructive sleep apnea (OSA) has been implicated as a possible additional risk factor for stroke. OSA is a common disorder characterized by repeated upper airway collapse during sleep leading to multiple physiologic abnormalities. Several recent studies suggest that OSA is an independent risk factor for stroke. This independent association is likely due to derangement of normal sleep physiology and the attendant consequences to autonomic, vascular endothelial, and thrombotic/fibrinolytic dysfunction leading to the development of atherosclerosis. Additionally, OSAs contribution to the development of known risk factors for stroke such as hypertension and atrial fibrillation may also predispose a patient to develop cerebrovascular disease. Patients presenting with stroke who are also diagnosed with OSA have a worse prognosis than those without OSA. Therapy with continuous positive airway pressure (CPAP), the treatment of choice for most patients with OSA, appears to be beneficial, but achieving compliance in patients post-stroke is difficult.
Keywords: non-rapid eye movement phase, cerebral blood flow, patent foramen ovale, CPAP therapy, Nitric oxide
Current Respiratory Medicine Reviews
Title: Obstructive Sleep Apnea and Stroke
Volume: 3 Issue: 4
Author(s): Philip M. Alapat
Affiliation:
Keywords: non-rapid eye movement phase, cerebral blood flow, patent foramen ovale, CPAP therapy, Nitric oxide
Abstract: Stroke is one of the leading causes of mortality, and several risk factors have been identified that may be modified to ameliorate this risk. Recently, obstructive sleep apnea (OSA) has been implicated as a possible additional risk factor for stroke. OSA is a common disorder characterized by repeated upper airway collapse during sleep leading to multiple physiologic abnormalities. Several recent studies suggest that OSA is an independent risk factor for stroke. This independent association is likely due to derangement of normal sleep physiology and the attendant consequences to autonomic, vascular endothelial, and thrombotic/fibrinolytic dysfunction leading to the development of atherosclerosis. Additionally, OSAs contribution to the development of known risk factors for stroke such as hypertension and atrial fibrillation may also predispose a patient to develop cerebrovascular disease. Patients presenting with stroke who are also diagnosed with OSA have a worse prognosis than those without OSA. Therapy with continuous positive airway pressure (CPAP), the treatment of choice for most patients with OSA, appears to be beneficial, but achieving compliance in patients post-stroke is difficult.
Export Options
About this article
Cite this article as:
Alapat M. Philip, Obstructive Sleep Apnea and Stroke, Current Respiratory Medicine Reviews 2007; 3 (4) . https://dx.doi.org/10.2174/157339807782359913
DOI https://dx.doi.org/10.2174/157339807782359913 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mechanisms of Action of Hypertonic Saline Resuscitation in Severe Sepsis and Septic Shock
Endocrine, Metabolic & Immune Disorders - Drug Targets The Physiology and Pathophysiology of a Novel Angiotensin Receptor-binding Protein ATRAP/Agtrap
Current Pharmaceutical Design Fast Food Versus Slow Food and Hypertension Control
Current Hypertension Reviews G Protein β γ Subunits as Targets for Small Molecule Therapeutic Development
Combinatorial Chemistry & High Throughput Screening Exploring New CGRP Family Peptides and their Receptors in Vertebrates
Current Protein & Peptide Science Virtue of Nanotechnology in Confronting Obesity: Recent Advances
Nanoscience & Nanotechnology-Asia The Role of Heat Shock Protein 90 and Endothelial Nitric Oxide Synthase Signaling in Cardiovascular Therapy
Current Signal Transduction Therapy A One Pot, Solvent Free and Catalyst Free Synthesis of Substituted 2-Amino-5-Aryl-1,3,4-Oxadiazoles under Microwave Irradiation
Current Microwave Chemistry Angiogenesis-regulating microRNAs and Ischemic Stroke
Current Vascular Pharmacology Resident and Non-Resident Stem Cells in Acute Myocardial Infarction
Cardiovascular & Hematological Disorders-Drug Targets Endocannabinoid Blockade and the Cardiovascular System
Current Drug Therapy Role of Glycogen Synthase Kinase-3 in Insulin Resistance and Type 2 Diabetes
Current Drug Targets The Effect of Chronic Co-Administration of Morphine and Verapamil on Isoproterenol-Induced Heart Injury
Cardiovascular & Hematological Agents in Medicinal Chemistry Olmesartan Associated Enteropathy: Usefulness of Video Capsule Endoscopy in a Case With Doubtful Upper Endoscopic/Histological Picture
Current Drug Safety Atrial Fibrillation: Epidemiology and Peculiarities in the Elderly
Cardiovascular & Hematological Agents in Medicinal Chemistry Marine Bioactive Peptides in Supplements and Functional Foods - A Commercial Perspective
Current Pharmaceutical Design Automated Electrophysiology in Drug Discovery
Current Pharmaceutical Design Hypercoagulability and Nephrotic Syndrome
Current Vascular Pharmacology The Role of Polyunsaturated Fatty Acids (PUFA) in the Treatment of Dyslipidemias
Current Pharmaceutical Design Role of 2-Antiplasmin in Cardiovascular System
Letters in Drug Design & Discovery